This Educational Update Session by Gaël Chételat, France, and Henrik Zetterberg, Sweden, was recorded on 7 October 2023 at the 36th ECNP Congress in Barcelona, Spain.
Growing evidence indicates that Alzheimer disease (AD) pathophysiological processes initiate decades before the onset of clinical signs and symptoms. Within the continuum of the disease, the symptomatic stage is preceded by a preclinical phase in asymptomatic individuals. Early biomarkers should inform on pathophysiological preclinical stages in cognitively unimpaired elderly individuals at-risk for AD.
This educational update aims at giving an overview of the latest knowledge on the preclinical phase of Alzheimer’s Disease. Moreover, both presenters will discuss ethical aspects related to preclinical AD detection, prevention and involvement in pharmacological clinical trials.
Views and opinions expressed in these videos are those of the presenters and do not necessarily reflect the official position of ECNP. The content of these videos should not be used in any way as the basis for treatment decisions.
